Jeremy Bender - Net Worth and Insider Trading
Jeremy Bender Net Worth
The estimated net worth of Jeremy Bender is at least $27 Million dollars as of 2024-05-14. Jeremy Bender is the CHIEF EXECUTIVE OFFICER of Day One Biopharmaceuticals Inc and owns about 1,686,326 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $27 Million. Details can be seen in Jeremy Bender's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeremy Bender has not made any transactions after 2024-05-03 and currently still holds the listed stock(s).
Transaction Summary of Jeremy Bender
Jeremy Bender Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy Bender owns 2 companies in total, including Day One Biopharmaceuticals Inc (DAWN) , and Fusion Pharmaceuticals Inc (FUSN) .
Click here to see the complete history of Jeremy Bender’s form 4 insider trades.
Insider Ownership Summary of Jeremy Bender
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2024-05-03 | director & Chief Executive Officer |
| FUSN | Fusion Pharmaceuticals Inc | 2023-10-16 | director |
Jeremy Bender Latest Holdings Summary
Jeremy Bender currently owns a total of 1 stock. Jeremy Bender owns 1,686,326 shares of Day One Biopharmaceuticals Inc (DAWN) as of May 3, 2024, with a value of $27 Million.
Latest Holdings of Jeremy Bender
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2024-05-03 | 1,686,326 | 16.05 | 27,065,532 |
Holding Weightings of Jeremy Bender
Jeremy Bender Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy Bender has made a total of 20 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the sale of 79,211 shares on May 3, 2024, which brought Jeremy Bender around $1 Million.
Insider Trading History of Jeremy Bender
- 1
Jeremy Bender Trading Performance
Jeremy Bender Ownership Network
Jeremy Bender Owned Company Details
What does Day One Biopharmaceuticals Inc do?
Who are the key executives at Day One Biopharmaceuticals Inc?
Jeremy Bender is the director & Chief Executive Officer of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include COO & CFO and Secretary York Charles N Ii , Chief Medical Officer Samuel C. Blackman , and 10 percent owner Ai Day 1 Llc .
Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary
Over the past 18 months, Jeremy Bender made 11 insider transaction in Day One Biopharmaceuticals Inc (DAWN) with a net sale of 150,568. Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 116,607 shares made by Samuel C. Blackman , a net sale of 106,697 shares made by York Charles N Ii , and a net sale of 89,358 shares made by Julie Papanek Grant .
In summary, during the past 3 months, insiders sold 225,453 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 225,453 shares. During the past 18 months, 471,785 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,772,899 shares.
Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Day One Biopharmaceuticals Inc Insider Transactions
Jeremy Bender Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy Bender. You might contact Jeremy Bender via mailing address: 395 Oyster Point Blvd., Suite 217, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
